"And we are seeing multiple reports of this as well," she said
Individuals considering GLP-1 agonists for binge eating disorder should engage in thorough, collaborative discussions with healthcare providers who understand both the medications and eating disorders
This study was carried out in accordance with the recommendations of the respective Institutional Review Boards (IRBs), described below with written informed consent from parents of subjects and assent where appropriate
There were no increases in pancreatitis or pancreatic cancer noted [11,14]
Perspectivas futuras Hoy en da, el arsenal farmacolgico disponible contempla el abordaje de nuevas patologas, como la enfermedad arterial perifrica o las afecciones neurodegenerativas, lo que refrenda el papel de las enfermedades metablicas en la fisiopatologa de diversos trastornos con un profundo impacto en la calidad y la expectativa de vida de la poblacin60
However, the current evidence suggests that most people can maintain their muscle health while using GLP-1s to lose weight provided they maintain proper nutrition and exercise regularly